Search research articles
Contact Us
Filters
Showing results (331-340 of 408) with videos related to
Page
of 41
Sort By:
Hepatology (Baltimore, Md.)
|
November 27, 2004
Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy
Paul J Pockros, Mitchell L Shiffman, Eugene R Schiff, et al.
Open Forum Infectious Diseases
|
November 16, 2018
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials
Jason Grebely, Massimo Puoti, Heiner Wedemeyer, et al.
Annals of Internal Medicine
|
May 21, 2013
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial
Mark S Sulkowski, Kenneth E Sherman, Douglas T Dieterich, et al.
Hepatology (Baltimore, Md.)
|
January 30, 2013
Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype 1 HCV: SILEN-C1 trial
Mark S Sulkowski, Tarik Asselah, Jacob Lalezari, et al.
Molecular Psychiatry
|
June 22, 2011
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
A K Smith, J S Simon, E L Gustafson, et al.
The Journal of Infectious Diseases
|
March 24, 2020
Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy
Ashwin Balagopal, Laura M Smeaton, Jeffrey Quinn, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2015
Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed
Stanislas Pol, Mark S Sulkowski, Tarek Hassanein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 6, 2024
Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIV
Ani Kardashian, Audrey Lloyd, Eduardo Vilar-Gomez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2021
Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection
Mandana Khalili, Wendy C King, David E Kleiner, et al.
Hepatology (Baltimore, Md.)
|
March 19, 2013
Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial
Mark S Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki, et al.
Page
of 41
Search research articles
Search
Showing results (331-340 of 408) with videos related to
Sort By:
Page
of 41
Hepatology (Baltimore, Md.)
|
November 27, 2004
Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy
Paul J Pockros, Mitchell L Shiffman, Eugene R Schiff, et al.
Open Forum Infectious Diseases
|
November 16, 2018
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials
Jason Grebely, Massimo Puoti, Heiner Wedemeyer, et al.
Annals of Internal Medicine
|
May 21, 2013
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial
Mark S Sulkowski, Kenneth E Sherman, Douglas T Dieterich, et al.
Hepatology (Baltimore, Md.)
|
January 30, 2013
Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype 1 HCV: SILEN-C1 trial
Mark S Sulkowski, Tarik Asselah, Jacob Lalezari, et al.
Molecular Psychiatry
|
June 22, 2011
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
A K Smith, J S Simon, E L Gustafson, et al.
The Journal of Infectious Diseases
|
March 24, 2020
Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy
Ashwin Balagopal, Laura M Smeaton, Jeffrey Quinn, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2015
Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed
Stanislas Pol, Mark S Sulkowski, Tarek Hassanein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 6, 2024
Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIV
Ani Kardashian, Audrey Lloyd, Eduardo Vilar-Gomez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2021
Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection
Mandana Khalili, Wendy C King, David E Kleiner, et al.
Hepatology (Baltimore, Md.)
|
March 19, 2013
Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial
Mark S Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki, et al.
Page
of 41